A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Adrian Liston Adrian Liston Adrian Liston VIB Translational Immunology Lab, KU Leuven, BE Nalan Liv Nalan Liv Nalan Liv UMC Utrecht, NL David Livingston David Livingston David Livingston Dana-Farber Cancer Institute, US Clare Lloyd Clare Lloyd Clare Lloyd Imperial College London, UK Christian Loch Christian Loch Christian Loch Director of Research & Development, AVMBioMed, US Richard M. Locksley Richard M. Locksley Richard M. Locksley University of California, San Francisco, US Nick Loman Nick Loman Nick Loman Institute of Microbiology and Infection, University of Birmingham, UK Horacio Londono-Ramirez Horacio Londono-Ramirez Horacio Londono-Ramirez Nerf, BE; imec, BE; KU Leuven, BE; VIB, BE Matt Loose Matt Loose Matt Loose University of Nottingham, UK Nuria Lopez-Bigas Nuria Lopez-Bigas Nuria Lopez-Bigas Institute for Research in Biomedicine (IRB Barcelona), ES Irena Loryan Irena Loryan Irena Loryan Uppsala University, SE Alrik Los Alrik Los Alrik Los Biotalys NV, BE Nikolaos Louros Nikolaos Louros Nikolaos Louros Switch Laboratory, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium, BE; Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium, BE J. Christopher Love J. Christopher Love J. Christopher Love Koch Institute for Integrative Cancer Research, MIT, US Sarah Lovelock Sarah Lovelock Sarah Lovelock University of Manchester, UK Pagination Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page Next ›
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Adrian Liston Adrian Liston Adrian Liston VIB Translational Immunology Lab, KU Leuven, BE Nalan Liv Nalan Liv Nalan Liv UMC Utrecht, NL David Livingston David Livingston David Livingston Dana-Farber Cancer Institute, US Clare Lloyd Clare Lloyd Clare Lloyd Imperial College London, UK Christian Loch Christian Loch Christian Loch Director of Research & Development, AVMBioMed, US Richard M. Locksley Richard M. Locksley Richard M. Locksley University of California, San Francisco, US Nick Loman Nick Loman Nick Loman Institute of Microbiology and Infection, University of Birmingham, UK Horacio Londono-Ramirez Horacio Londono-Ramirez Horacio Londono-Ramirez Nerf, BE; imec, BE; KU Leuven, BE; VIB, BE Matt Loose Matt Loose Matt Loose University of Nottingham, UK Nuria Lopez-Bigas Nuria Lopez-Bigas Nuria Lopez-Bigas Institute for Research in Biomedicine (IRB Barcelona), ES Irena Loryan Irena Loryan Irena Loryan Uppsala University, SE Alrik Los Alrik Los Alrik Los Biotalys NV, BE Nikolaos Louros Nikolaos Louros Nikolaos Louros Switch Laboratory, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium, BE; Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium, BE J. Christopher Love J. Christopher Love J. Christopher Love Koch Institute for Integrative Cancer Research, MIT, US Sarah Lovelock Sarah Lovelock Sarah Lovelock University of Manchester, UK Pagination Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page Next ›
Richard M. Locksley Richard M. Locksley Richard M. Locksley University of California, San Francisco, US
Nick Loman Nick Loman Nick Loman Institute of Microbiology and Infection, University of Birmingham, UK
Horacio Londono-Ramirez Horacio Londono-Ramirez Horacio Londono-Ramirez Nerf, BE; imec, BE; KU Leuven, BE; VIB, BE
Nuria Lopez-Bigas Nuria Lopez-Bigas Nuria Lopez-Bigas Institute for Research in Biomedicine (IRB Barcelona), ES
Nikolaos Louros Nikolaos Louros Nikolaos Louros Switch Laboratory, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium, BE; Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, 3000 Leuven, Belgium, BE
J. Christopher Love J. Christopher Love J. Christopher Love Koch Institute for Integrative Cancer Research, MIT, US
